Literature DB >> 7149799

Anticentromere antibody in primary biliary cirrhosis.

R M Bernstein, M E Callender, J M Neuberger, G R Hughes, R Williams.   

Abstract

An autoantibody specific for the centromere region of chromosomes and recently detected in the serum of patients with scleroderma was found in ther serum of 10 (9.1%) of 110 consecutive patients presenting with primary biliary cirrhosis. It was found exclusively among those with scleroderma, giving a prevalence of 50% in that group, and all patients with telangiectasia or calcinosis had the antibody. It was not found in 80 patients with chronic active hepatitis, including the 'autoimmune' variety. The pathogenetic significance of anticentromere antibody is not yet established, but this study confirms its specificity for scleroderma in the context of primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7149799      PMCID: PMC1000995          DOI: 10.1136/ard.41.6.612

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Primary biliary cirrhosis and scleroderma.

Authors:  P J August
Journal:  Proc R Soc Med       Date:  1974-12

2.  Primary biliary cirrhosis associated with scleroderma.

Authors:  S T O'Brien; W M Eddy; E L Krawitt
Journal:  Gastroenterology       Date:  1972-01       Impact factor: 22.682

3.  Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome.

Authors:  T B Reynolds; E K Denison; H D Frankl; F L Lieberman; R L Peters
Journal:  Am J Med       Date:  1971-03       Impact factor: 4.965

4.  Rheumatic disorders in primary biliary cirrhosis.

Authors:  A K Clarke; R M Galbraith; E B Hamilton; R Williams
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

5.  [Chromosome anomalies in generalized scleroderma. A study of 6 patients].

Authors:  E Housset; I Emerit; A Baulon; J de Grouchy
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1969

6.  Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).

Authors:  N F Rothfield; G P Rodnan
Journal:  Arthritis Rheum       Date:  1968-10

7.  Scleroderma and primary biliary cirrhosis.

Authors:  I M Murray-Lyon; R P Thompson; I D Ansell; R Williams
Journal:  Br Med J       Date:  1970-08-01

8.  Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors:  Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.

Authors:  E M Tan; G P Rodnan; I Garcia; Y Moroi; M J Fritzler; C Peebles
Journal:  Arthritis Rheum       Date:  1980-06

10.  Endothelial injury in scleroderma.

Authors:  M B Kahaleh; G K Sherer; E C LeRoy
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  32 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

Review 2.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

3.  Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis.

Authors:  C Rigamonti; L M Shand; M Feudjo; C C Bunn; C M Black; C P Denton; A K Burroughs
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

4.  Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis.

Authors:  A Ruffatti; P Arslan; A Floreani; G De Silvestro; A Calligaro; R Naccarato; S Todesco
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

5.  Anticentromere antibody--clinical associations. A study of 44 patients.

Authors:  P Caramaschi; D Biasi; T Manzo; A Carletto; F Poli; L M Bambara
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

6.  Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjögren's syndrome.

Authors:  Tetsutaro Kitagawa; Koichi Shibasaki; Shuji Toya
Journal:  Clin Rheumatol       Date:  2011-06-14       Impact factor: 2.980

7.  Immunomorphological characterisation of antinuclear antibodies in chronic liver disease.

Authors:  F Cassani; F B Bianchi; M Lenzi; U Volta; E Pisi
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

8.  Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.

Authors:  N J McHugh; J Whyte; C Artlett; D C Briggs; C O Stephens; N J Olsen; N G Gusseva; P J Maddison; C M Black; K Welsh
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Specificity of antinuclear antibodies in primary biliary cirrhosis.

Authors:  M J Chou; S L Lee; T Y Chen; G J Tsay
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

10.  The value of antinuclear antibodies in primary biliary cirrhosis.

Authors:  Lixia Gao; Xinping Tian; Bin Liu; Fengchun Zhang
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.